Logo image of BFRG

BULLFROG AI HOLDINGS INC (BFRG) Stock Fundamental Analysis

NASDAQ:BFRG - Nasdaq - US12021E1091 - Common Stock - Currency: USD

2.86  +0.29 (+11.28%)

After market: 3.04 +0.18 (+6.29%)

Fundamental Rating

2

Overall BFRG gets a fundamental rating of 2 out of 10. We evaluated BFRG against 39 industry peers in the Health Care Technology industry. The financial health of BFRG is average, but there are quite some concerns on its profitability. BFRG is valued expensive and it does not seem to be growing.


Dividend Valuation Growth Profitability Health

Quickly go to:

0

1. Profitability

1.1 Basic Checks

BFRG had negative earnings in the past year.
In the past year BFRG has reported a negative cash flow from operations.
BFRG Yearly Net Income VS EBIT VS OCF VS FCFBFRG Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2020 2021 2022 2023 -2M -4M -6M

1.2 Ratios

The Return On Assets of BFRG (-143.25%) is worse than 83.78% of its industry peers.
BFRG's Return On Equity of -172.44% is on the low side compared to the rest of the industry. BFRG is outperformed by 72.97% of its industry peers.
Industry RankSector Rank
ROA -143.25%
ROE -172.44%
ROIC N/A
ROA(3y)-3197.63%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BFRG Yearly ROA, ROE, ROICBFRG Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2020 2021 2022 2023 0 -2K -4K

1.3 Margins

BFRG does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM N/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BFRG Yearly Profit, Operating, Gross MarginsBFRG Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2020 2021 2022 2023 0 -5K -10K -15K -20K -25K

More info and screens

6

2. Health

2.1 Basic Checks

BFRG does not have a ROIC to compare to the WACC, probably because it is not profitable.
BFRG has about the same amout of shares outstanding than it did 1 year ago.
There is no outstanding debt for BFRG. This means it has a Debt/Equity and Debt/FCF ratio of 0 and it is amongst the best of the sector and industry.
BFRG Yearly Shares OutstandingBFRG Yearly Shares OutstandingYearly Shares Outstanding 2020 2021 2022 2023 2M 4M 6M
BFRG Yearly Total Debt VS Total AssetsBFRG Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2020 2021 2022 2023 500K 1M 1.5M 2M 2.5M

2.2 Solvency

BFRG has an Altman-Z score of 8.78. This indicates that BFRG is financially healthy and has little risk of bankruptcy at the moment.
With an excellent Altman-Z score value of 8.78, BFRG belongs to the best of the industry, outperforming 86.49% of the companies in the same industry.
A Debt/Equity ratio of 0.04 indicates that BFRG is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.04, BFRG is in line with its industry, outperforming 56.76% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Altman-Z 8.78
ROIC/WACCN/A
WACC9.49%
BFRG Yearly LT Debt VS Equity VS FCFBFRG Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2020 2021 2022 2023 0 2M -2M -4M -6M

2.3 Liquidity

A Current Ratio of 5.90 indicates that BFRG has no problem at all paying its short term obligations.
The Current ratio of BFRG (5.90) is better than 94.59% of its industry peers.
BFRG has a Quick Ratio of 5.90. This indicates that BFRG is financially healthy and has no problem in meeting its short term obligations.
With an excellent Quick ratio value of 5.90, BFRG belongs to the best of the industry, outperforming 94.59% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 5.9
Quick Ratio 5.9
BFRG Yearly Current Assets VS Current LiabilitesBFRG Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2020 2021 2022 2023 1M 2M 3M

More info and screens

0

3. Growth

3.1 Past

The earnings per share for BFRG have decreased by -3.08% in the last year.
The Revenue for BFRG has decreased by -100.00% in the past year. This is quite bad
EPS 1Y (TTM)-3.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3.36%
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
BFRG Yearly Revenue VS EstimatesBFRG Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2020 2021 2022 2023 20K 40K 60K
BFRG Yearly EPS VS EstimatesBFRG Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023

More info and screens

0

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for BFRG. In the last year negative earnings were reported.
Industry RankSector Rank
PE N/A
Fwd PE N/A
BFRG Price Earnings VS Forward Price EarningsBFRG Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BFRG Per share dataBFRG EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.2 -0.2 0.4 -0.4 -0.6 -0.8

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

0

5. Dividend

5.1 Amount

No dividends for BFRG!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BULLFROG AI HOLDINGS INC

NASDAQ:BFRG (2/7/2025, 8:13:38 PM)

After market: 3.04 +0.18 (+6.29%)

2.86

+0.29 (+11.28%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)N/A N/A
Earnings (Next)N/A N/A
Inst Owners3.86%
Inst Owner Change-0.33%
Ins Owners31.71%
Ins Owner ChangeN/A
Market Cap24.91M
AnalystsN/A
Price TargetN/A
Short Float %3.89%
Short Ratio0.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)N/A
PT rev (3m)N/A
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S N/A
P/FCF N/A
P/OCF N/A
P/B 6.52
P/tB 6.52
EV/EBITDA N/A
EPS(TTM)-0.86
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.62
FCFYN/A
OCF(TTM)-0.62
OCFYN/A
SpS0
BVpS0.44
TBVpS0.44
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -143.25%
ROE -172.44%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM N/A
FCFM N/A
ROA(3y)-3197.63%
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-Score2
Asset Turnover0
Health
Industry RankSector Rank
Debt/Equity 0.04
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 5.9
Quick Ratio 5.9
Altman-Z 8.78
F-Score2
WACC9.49%
ROIC/WACCN/A
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.08%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-3.36%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-100%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-100%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-47.58%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-452.53%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-458.28%
OCF growth 3YN/A
OCF growth 5YN/A